Mary Katofiasc Selected Research

Glutamic Acid (Glutamate)

8/2006

Pharmacological characterization of the competitive GLUK5 receptor antagonist decahydroisoquinoline LY466195 in vitro and in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mary Katofiasc Research Topics

Disease

3	Hypotension (Low Blood Pressure) 01/2018 - 01/2018
1	Spinal Cord Injuries (Spinal Cord Injury) 01/2018
1	Vomiting 01/2018
1	Migraine Disorders (Migraine) 08/2006
1	Pain (Aches) 08/2006

Drug/Important Bio-Agent (IBA)

3	3- (2- methoxybenzylamino)- 2- phenylpiperidineIBA 01/2018 - 01/2018
1	Neurokinin-2 Receptors (Neurokinin 2 Receptor)IBA 01/2018
1	lysyl(3)-glycyl(8)-R-lactam-leucine(9)- neurokinin A (3-10)IBA 01/2018
1	GR 159897IBA 01/2018
1	Glutamic Acid (Glutamate)FDA Link 08/2006
1	6- ((2- carboxy- 4,4- difluoro- 1- pyrrolidinyl)methyl)decahydro- 3- isoquinolinecarboxylic acidIBA 08/2006
1	Blood Proteins (Serum Proteins)IBA 08/2006
1	Neurotransmitter Agents (Neurotransmitter)IBA 08/2006

Therapy/Procedure

1	Therapeutics 01/2018